Wordt geladen...
A dose-finding study of carboplatin–epirubicin–docetaxel in advanced epithelial ovarian cancer
The docetaxel–carboplatin combination is active and well tolerated in patients with epithelial ovarian cancer. We added epirubicin to this combination to investigate additional benefits of anthracyclines in epithelial ovarian cancer. Twenty-one patients, FIGO Ic-IV, performance status 0–1, were trea...
Bewaard in:
| Hoofdauteurs: | , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Nature Publishing Group
2002
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2375366/ https://ncbi.nlm.nih.gov/pubmed/11986768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600259 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|